Statement of Principles concerning malignant neoplasm of the small intestine No. 41 of 2004

Administered by Department of Veterans' Affairs

Legislation au F2005B02529 Not in force Legislative Instrument

Legislation content

Instrument No. 41 of 2004

 

Revocation and Determination

of

Statement of Principles

concerning

 

MALIGNANT NEOPLASM OF THE SMALL INTESTINE

 

 

for the purposes of the

 

Veterans’ Entitlements Act 1986

and

Military Rehabilitation and Compensation Act 2004

 

1. The Repatriation Medical Authority under subsection 196B(3) and (8) of the Veterans’ Entitlements Act 1986 (the VEA):

 

(a) revokes Instrument No. 154 of 1996, as amended by Instrument No. 8 of 1998; and

 

(b) determines in their place the following Statement of Principles.

 

Kind of injury, disease or death

2. (a) This Statement of Principles is about malignant neoplasm of the small intestine  and death from malignant neoplasm of the small intestine.

(b)              For the purposes of this Statement of Principles, “malignant neoplasm of the small intestine ” means a primary malignant neoplasm arising from the epithelial cells of the small intestine. The small intestine is defined as the proximal portion of the intestine comprising the duodenum, jejunum and ileum, excluding the pyloric opening of the stomach and the ileocaecal junction. This definition excludes soft tissue sarcoma, carcinoid tumour, non-Hodgkin’s lymphoma and Hodgkin’s lymphoma.

 

(c)               Malignant neoplasm of the small intestine attracts ICD-10-AM code C17.

(d)              In the application of this Statement of Principles, the definition of “malignant neoplasm of the small intestine” is that given at paragraph 2(b) above.

 

Basis for determining the factors

3. On the sound medical-scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that malignant neoplasm of the small intestine and death from malignant neoplasm of the small intestine can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the Military Rehabilitation and Compensation Act 2004 (the MRCA).

 

Factors that must be related to service

4. Subject to clause 6, at least one of the factors set out in clause 5 must be related to the relevant service rendered by the person.

 

Factors

5. The factor that must exist before it can be said that, on the balance of probabilities, malignant neoplasm of the small intestine or death from malignant neoplasm of the small intestine is connected with the circumstances of a person’s relevant service is:

 

(a)               having Crohn’s disease of the small intestine before the clinical onset of malignant neoplasm of the small intestine; or

 

(b) having coeliac disease before the clinical onset of malignant neoplasm of the small intestine; or

 

(c)               having an adenoma of the small intestine before the clinical onset of malignant neoplasm of the small intestine; or

 

(d)              for adenocarcinoma involving an ileostomy or ileal pouch only, having an ileostomy or ileal pouch for at least two years before the clinical onset of malignant neoplasm of the small intestine; or

 

(e)               inability to obtain appropriate clinical management for malignant neoplasm of the small intestine.

 

 

Factors that apply only to material contribution or aggravation

6. Paragraph 5(e) applies only to material contribution to, or aggravation of, malignant neoplasm of the small intestine where the person’s malignant neoplasm of the small intestine was suffered or contracted before or during (but not arising out of) the person’s relevant service.

 

Inclusion of Statements of Principles

7. In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles.

 

Other definitions

8. For the purposes of this Statement of Principles:

 

“Crohn’s disease” means a type of inflammatory bowel disease affecting any part of the gastrointestinal tract, which is characterised by chronic inflammation which may extend through all layers of the gastrointestinal tract wall, and is also known as regional enteritis;

 

“death from malignant neoplasm of the small intestine ” in relation to a person includes death from a terminal event or condition that was contributed to by the person’s malignant neoplasm of the small intestine;

 

“ICD-10-AM code” means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th revision, Australian Modification (ICD-10-AM), Fourth Edition, effective date of 1 July 2004, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 1 86487 594 1;

 

“relevant service” means:

(a) eligible war service (other than operational service) under the VEA; or

(b)              defence service (other than hazardous service) under the VEA; or

(c)               peacetime service under the MRCA;

 

 

 

 

 

 

 

“terminal event” means the proximate or ultimate cause of death and includes:

(a) pneumonia;

(b) respiratory failure;

(c) cardiac arrest;

(d) circulatory failure; or

(e) cessation of brain function.

 

Application

9. This Instrument applies to all matters to which section 120B of the VEA or section 339 of the MRCA applies.

 

Dated this tenth day of  November  2004

 

 

The Common Seal of the    )

Repatriation Medical Authority   )

was affixed to this instrument  )

in the presence of:    )

 

KEN DONALD

CHAIRMAN

Overview

This legislative instrument, F2005B02529, was enacted in 2004 by the Repatriation Medical Authority under the authority of the Veterans’ Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). The primary objective of this instrument is to address the problem of establishing a link between service-related conditions and malignant neoplasm of the small intestine, including death from this condition, for veterans and members of the Australian Defence Force. The instrument revokes the previous Statement of Principles concerning malignant neoplasm of the small intestine and introduces new principles that provide a clearer framework for determining the relationship between the disease and relevant military service. The new Statement of Principles specifies certain pre-existing conditions and circumstances that must be related to the service to establish a connection, ensuring that affected individuals can receive appropriate benefits and compensation.

Scope and Application

The legislative instrument No. 41 of 2004, concerning the Statement of Principles for malignant neoplasm of the small intestine under the Veterans’ Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA), revokes the previous Instrument No. 154 of 1996 as amended, and establishes new criteria for determining eligibility for compensation or rehabilitation benefits. This instrument applies to veterans or members of the Australian Defence Force who have developed malignant neoplasm of the small intestine or have died from such a condition, provided that the disease is linked to their service under the VEA or MRCA. The small intestine is defined as the proximal portion comprising the duodenum, jejunum, and ileum, excluding certain conditions such as soft tissue sarcoma, carcinoid tumour, non-Hodgkin’s lymphoma, and Hodgkin’s lymphoma. The instrument specifies that the development of malignant neoplasm of the small intestine can be related to relevant service if certain pre-existing conditions or circumstances are present, such as Crohn’s disease, coeliac disease, adenoma of the small intestine, or inability to obtain appropriate clinical management. These factors must be related to the individual’s relevant service, with specific conditions applying to material contribution or aggravation of the disease. The instrument extends to all matters covered by section 120B of the VEA or section 339 of the MRCA, governing the application and interpretation of these provisions in the context of veterans' entitlements and military compensation.

Key Provisions

The primary sections of this legislative instrument (Instrument No. 41 of 2004) involve the revocation of the previous Statement of Principles concerning malignant neoplasm of the small intestine (Instrument No. 154 of 1996) and the introduction of a new Statement of Principles (sections 1 and 2). This new Statement of Principles defines malignant neoplasm of the small intestine as a primary malignant neoplasm arising from the epithelial cells of the small intestine, which is classified under ICD-10-AM code C17. The document specifies that the small intestine includes the duodenum, jejunum, and ileum, while excluding the pyloric opening of the stomach and the ileocaecal junction. It further clarifies that this definition excludes certain conditions such as soft tissue sarcoma, carcinoid tumour, non-Hodgkin’s lymphoma, and Hodgkin’s lymphoma. The Repatriation Medical Authority, based on the available medical-scientific evidence, has determined that there is a probable relationship between malignant neoplasm of the small intestine, death from such neoplasm, and the relevant service rendered by veterans or members of the Forces under the Veterans’ Entitlements Act 1986 (VEA) or members under the Military Rehabilitation and Compensation Act 2004 (MRCA). To establish this connection, at least one of the specified factors must be related to the person's relevant service. These factors include having Crohn’s disease, coeliac disease, an adenoma of the small intestine, or an ileostomy or ileal pouch for at least two years before the clinical onset of malignant neoplasm of the small intestine, or being unable to obtain appropriate clinical management for the condition (section 5). Obligations under this Act include the requirement that claimants or their representatives provide evidence of the presence of one of the specified factors before the onset of malignant neoplasm of the small intestine or death from such neoplasm. Additionally, if the malignant neoplasm of the small intestine was suffered or contracted before or during service, the inability to obtain appropriate clinical management must be linked to the service. Furthermore, if a relevant factor includes an injury or disease with an existing Statement of Principles, the terms of that Statement must also be adhered to (section 6). The instrument applies to all matters governed by section 120B of the VEA or section 339 of the MRCA (section 9). The legislative instrument does not explicitly detail offences, penalties, or civil/criminal consequences for breach within its text. However, breaches of related Acts such as the VEA and MRCA may incur penalties as stipulated in those respective Acts, which could include fines or imprisonment, depending on the nature and severity of the breach. The exact penalties would need to be referenced within the broader legislative framework of the VEA and MRCA.

Legal classification tags

Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Regulatory Standards
Reporting & Disclosure Obligations

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.